Medical Xpress news

Medical Xpress / Foreign aid cuts to tuberculosis services could cost families $80 billion worldwide

More than a year after the second Trump administration began dismantling the US Agency for International Development (USAID), the global health consequences of this unprecedented loss in international aid continue to surface. ...

Mar 11, 2026
Medical Xpress / Claims data study ties epilepsy drugs in pregnancy to developmental risks

Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and indicate no substantial risk ...

Mar 11, 2026
Medical Xpress / Safer blood clot treatment: Apixaban beats rivaroxaban in head-to-head comparison

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, ...

Mar 11, 2026
Medical Xpress / Study finds ALS drug hope via AI and veteran records

A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified several existing medications ...

Mar 11, 2026
Medical Xpress / Epstein-Barr virus antibodies can distinguish MS from other neuroinflammatory diseases

The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this week in JAMA Neurology by a team of international researchers, including one from the University ...

Mar 11, 2026
Medical Xpress / A workout playlist for your heart? Why musical structure could guide rehab

New findings on how the human heart adapts to expressive music features, like loudness or tempo, could lay the foundations for targeted music-based "exercises" to support heart health. Led by King's College London, the study ...

Mar 11, 2026
Medical Xpress / Dengue vaccine remains 80.5% effective against severe cases after five years

In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results ...

Mar 11, 2026
Medical Xpress / Adults with concurrent hearing and vision loss report barriers in navigating complex, everyday environments

According to a recent multi-institute PLOS One study led by the Multisensory Research Lab at the Wilmer Eye Institute, Johns Hopkins Medicine, time of hearing loss onset is a key determinant of patient confidence and self-reported ...

Mar 11, 2026
Medical Xpress / Clarifying how ketogenic diets treat epilepsy to guide future therapy development

Published in The Lancet Neurology, a new review from the University of Colorado Anschutz in collaboration with UT Southwestern Medical Center, offers the latest scientific explanations for why ketogenic diets reduce seizures ...

Mar 11, 2026
Medical Xpress / Eating more ultra-processed foods linked to poorer bone health, study finds

From flavored yogurts to frozen pizzas, breakfast cereals and instant oats, ultra-processed foods are convenient, often cheaper items designed for a quick bite. In recent years, excess consumption of these foods has also ...

Mar 11, 2026
Medical Xpress / A new tool to predict physical health risks in young people with psychosis

A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes.

Mar 11, 2026
Medical Xpress / Marburg virus invades human cells far more efficiently than Ebola, study reveals

In a new study published in Nature, University of Minnesota researchers have found that the Marburg virus, one of the world's deadliest pathogens with an average 73% fatality rate, is unusually efficient at getting inside ...

Mar 11, 2026